Modified method of AgNOR staining for tissue and interpretation in histopathology.
This study was conducted in the department of Pathology King Edward Medical University, from June to December 2002 to introduce the new method of AgNOR staining and its interpretation to increase its reliability. A total of 60 brain specimens were stained with modified AgNOR technique. The diagnosis of malignancy was made on H & E staining. AgNOR counts, variation in size and dispersion of AgNOR dots in cells were graded and compared in malignant and non-malignant lesions. Modified method of AgNOR staining and interpretation was an easy, reliable and reproducible alternative to traditional AgNOR techniques for evaluating proliferation activity of cells in malignant and benign brain lesions. mAgNOR counts of different grades of astrocytoma (2.97+/-0.96, 3.97+/-0.43, 6.01+/-2.74 and 8.01+/-3.56) were significantly (P<0.01) greater when compared with counts of normal brain (0.40+/-0.01), and reactive gliosis (0.60+/-0.01). AgNOR size and dispersion were of higher grade in a significantly greater proportion of malignancy when compared with benign conditions (P<0.05). The AgNOR dots were brighter and more clear with modified staining when compared with previous studies. We conclude that modified AgNOR staining technique is simple, quick and reliable to evaluate cell proliferation by detecting AgNORs size and dispersion. In future, AgNOR size and dispersion should be considered rather than the count only. We recommend the use of morphometry for AgNOR size in future. We also recommend the use of modified AgNOR staining for obtaining sound and confidant results in routine paraffin sections.
Bukhari
Mulazim Hussain
MH
Department of Pathology and Medicine, King Edward Medical University and Mayo Hospital, Lahore, Pakistan. drmhbukhari@yahoo.com
Niazi
Shahida
S
Khan
Saeed Akhter
SA
Hashmi
Ihsanulla
I
Perveen
Shahida
S
Qureshi
Shahzad Shafqat
SS
Chaudhry
Naseer Ahmed
NA
Qureshi
G R
GR
Hasan
Mumtaz
M
D034961:Antigens, Nuclear / Q000032:analysis*; D001254:Astrocytoma / Q000175:diagnosis*; D015415:Biomarkers / Q000032:analysis; D001921:Brain / Q000473:pathology*; D001932:Brain Neoplasms / Q000175:diagnosis*; D016022:Case-Control Studies; D049109:Cell Proliferation; D006801:Humans; D009687:Nuclear Proteins / Q000032:analysis*; D016612:Paraffin Embedding; D016622:Silver Staining / Q000379:methods*
D034961:Antigens, Nuclear; D015415:Biomarkers; D009687:Nuclear Proteins; C051963:nucleolar organizer region associated proteins